Home/Filings/4/0001144204-18-047656
4//SEC Filing

Kraus Al 4

Accession 0001144204-18-047656

CIK 0001175151other

Filed

Aug 30, 8:00 PM ET

Accepted

Aug 31, 8:19 PM ET

Size

13.4 KB

Accession

0001144204-18-047656

Insider Transaction Report

Form 4
Period: 2018-08-30
Kraus Al
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2018-08-30$2.10/sh+8,000$16,800133,046 total
  • Exercise/Conversion

    Common Stock

    2018-08-30$4.20/sh+18,000$75,600151,046 total
  • Sale

    Common Stock

    2018-08-30$14.47/sh26,000$376,282125,046 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-08-308,0000 total
    Exercise: $2.10From: 2009-01-08Exp: 2019-01-08Common Stock (8,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-08-3018,0000 total
    Exercise: $4.20Exp: 2019-01-28Common Stock (18,000 underlying)
Footnotes (3)
  • [F1]The stock options issued to the reporting person became exercisable according to the following vesting schedule: 4,500 stock options vested on 1/28/2009; 4,500 stock options vested on 1/28/2010; 4,500 stock options vested on 1/28/2011; and 4,500 stock options vested on 1/28/2012.
  • [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.45 to $14.605. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F3]Includes (a) the following restricted stock units subject to vesting upon a "Change in Control" of CytoSorbents Corporation (the "Company"), as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan: (i) 3,300 restricted stock units granted on March 15, 2018, (ii) 6,000 restricted stock units granted on February 24, 2017, (iii) 5,000 restricted stock units granted on June 7, 2016, and (iv) 55,000 restricted stock units granted on April 8, 2015, and (b) 55,746 shares of common stock owned by the reporting person.

Issuer

Cytosorbents Corp

CIK 0001175151

Entity typeother

Related Parties

1
  • filerCIK 0001368152

Filing Metadata

Form type
4
Filed
Aug 30, 8:00 PM ET
Accepted
Aug 31, 8:19 PM ET
Size
13.4 KB